The aim was to investigate if polymorphisms in the FADS gene cluster and the ELOVL2 gene were associated with the proportions of PUFAs in serum phospholipids from newborn infants and adolescents or with allergy development in a Swedish birth cohort. The gene discussed is ELOVL2; the disease is allergic disease.